{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T01:06:54Z","timestamp":1654909614442},"reference-count":29,"publisher":"Society of Nuclear Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.2967\/jnumed.118.208744","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T22:55:15Z","timestamp":1524783315000},"page":"1551-1557","source":"Crossref","is-referenced-by-count":1,"title":["Imaging Melphalan Therapy Response in Preclinical Extramedullary Multiple Myeloma with <sup>18<\/sup>F-FDOPA and <sup>18<\/sup>F-FDG PET"],"prefix":"10.2967","volume":"59","author":[{"given":"Deep K.","family":"Hathi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth N.","family":"DeLassus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Achilefu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"McConathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Shokeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1602","published-online":{"date-parts":[[2018,4,26]]},"reference":[{"key":"2021051712123119000_59.10.1551.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1011442"},{"key":"2021051712123119000_59.10.1551.2","doi-asserted-by":"crossref","unstructured":"Becker N . Epidemiology of multiple myeloma. In: Moehler T Goldschmidt H , eds. Multiple Myeloma. New York, NY: Springer; 2011:25\u201335.","DOI":"10.1007\/978-3-540-85772-3_2"},{"key":"2021051712123119000_59.10.1551.3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-104984"},{"key":"2021051712123119000_59.10.1551.4","unstructured":"Cancer stat facts: myeloma. Surveillance, Epidemiology, and End Results Program website. https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html. Accessed May 30, 2018."},{"key":"2021051712123119000_59.10.1551.5","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.122"},{"key":"2021051712123119000_59.10.1551.6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-237974"},{"key":"2021051712123119000_59.10.1551.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61537-2"},{"key":"2021051712123119000_59.10.1551.8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0005-2736(02)00516-3","article-title":"Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells","volume":"1565","author":"Kim","year":"2002","journal-title":"Biochim Biophys Acta."},{"key":"2021051712123119000_59.10.1551.9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1476-5586(04)80054-X","article-title":"L-type amino acid transporter-1 overexpression and melphalan sensitivity in Barrett\u2019s adenocarcinoma","volume":"6","author":"Lin","year":"2004","journal-title":"Neoplasia."},{"key":"2021051712123119000_59.10.1551.10","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12529"},{"key":"2021051712123119000_59.10.1551.11","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-3745"},{"key":"2021051712123119000_59.10.1551.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-2736(01)00384-4"},{"key":"2021051712123119000_59.10.1551.13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.biocel.2015.08.004","article-title":"LAT1 is the transport competent unit of the LAT1\/CD98 heterodimeric amino acid transporter","volume":"67","author":"Napolitano","year":"2015","journal-title":"Int J Biochem Cell Biol."},{"key":"2021051712123119000_59.10.1551.14","doi-asserted-by":"crossref","first-page":"C1077","DOI":"10.1152\/ajpcell.2001.281.4.C1077","article-title":"Function and structure of heterodimeric amino acid transporters","volume":"281","author":"Wagner","year":"2001","journal-title":"Am J Physiol Cell Physiol."},{"key":"2021051712123119000_59.10.1551.15","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.71"},{"key":"2021051712123119000_59.10.1551.16","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.12.9653"},{"key":"2021051712123119000_59.10.1551.17","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/S1470-2045(17)30189-4","article-title":"Role of 18F-FDG PET\/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group","volume":"18","author":"Cavo","year":"2017","journal-title":"Lancet Oncol."},{"key":"2021051712123119000_59.10.1551.18","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-012-0986-1"},{"key":"2021051712123119000_59.10.1551.19","doi-asserted-by":"crossref","unstructured":"Schwarzenberg J Czernin J Cloughesy TF . Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy. Clin Cancer Res. 2014;20:3550\u20133559.","DOI":"10.1158\/1078-0432.CCR-13-1440"},{"key":"2021051712123119000_59.10.1551.20","first-page":"1161","article-title":"Imaging of advanced neuroendocrine tumors with 18F-FDOPA PET","volume":"45","author":"Becherer","year":"2004","journal-title":"J Nucl Med."},{"key":"2021051712123119000_59.10.1551.21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0236"},{"key":"2021051712123119000_59.10.1551.22","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.183335"},{"key":"2021051712123119000_59.10.1551.23","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.093443"},{"key":"2021051712123119000_59.10.1551.24","doi-asserted-by":"publisher","DOI":"10.1177\/002215540004801007"},{"key":"2021051712123119000_59.10.1551.25","first-page":"248","article-title":"Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F]fluoro-L-dopa with 18F-FDG and 15O-water using compartment and noncompartment analysis","volume":"42","author":"Dimitrakopoulou-Strauss","year":"2001","journal-title":"J Nucl Med."},{"key":"2021051712123119000_59.10.1551.26","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.116.308335"},{"key":"2021051712123119000_59.10.1551.27","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-010-0117-9"},{"key":"2021051712123119000_59.10.1551.28","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0235"},{"key":"2021051712123119000_59.10.1551.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2009.03.026"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.118.208744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:31:32Z","timestamp":1621283492000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.118.208744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,26]]},"references-count":29,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10,1]]},"published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.2967\/jnumed.118.208744"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.118.208744","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,26]]}}}